Entropy Technologies’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$480K Buy
+2,494
New +$269K 0.02% 843
2025
Q3
– Sell
-20,019
Closed -$552K – 993
2025
Q2
$552K Buy
+20,019
New +$527K 0.04% 449
2024
Q4
– Sell
-11,637
Closed -$778K – 902
2024
Q3
$778K Buy
+11,637
New +$1.07M 0.08% 326

Other funds holding MRNA

Entropy Technologies's MRNA Position: Q3 2026 in Review

Entropy Technologies opened a new position in Moderna (MRNA) in Q3 2026: 2,494 shares worth $480K. The stake represents 0.02% of the portfolio and ranks #843 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in MRNA as recently as Q2 2025.

Entropy Technologies first reported a position in MRNA in Q3 2024 and has held it in 3 quarters since. The position peaked at $778K in Q3 2024. 1,044 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Entropy Technologies held 2,494 shares of Moderna worth $480K as of Q3 2026.
  • Moderna was a new Entropy Technologies position in Q3 2026.
  • Moderna made up 0.02% of Entropy Technologies's portfolio in Q3 2026, its #843 holding.
  • Entropy Technologies first reported a position in Moderna in Q3 2024 and has held it in 3 quarters since.
  • Entropy Technologies's Moderna position peaked at $778K in Q3 2024.
  • 1,044 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Entropy Technologies's 13F filing for Q3 2026, filed 13 Nov 2026.